Wealthcreatures.com
1.42K subscribers
1.19K photos
48 videos
40 files
1.54K links
Visit us at www.wealthcreatures.com

Driven by Fundamentals and Leveraging Technicals.

All post are Only For Study & Educational Purpose.consult you Financial Advisor Before Investing or taking any position.
DISCLAIMER:We r Not SEBI REGISTERED ANALYST.
Download Telegram
BOROSIL RENEWABLE

CMP - 272

ACCMULATION- 260 TO 272

Support @ 260

TEST LEVELS # 300/315/333++

TF - 30 to 45 DAYS

S/L - 254.50 on closing basis or As per Risk
1 stock From these Blasted šŸ’„šŸ’£ 5% after it was in red in morning.


Seems like big Rally coming in few days

3 Breakout Stocks.

2 Safe
1 A bit Risky

All Stocks Available at Cheap Valuations.

Low PE

If we get more then 25 Likes then:

1 Stock Comming from SmallCap Space Ready for Double.

#Share #Like

www.wealthcreatures.com

https://youtu.be/HFTejXRRn0c
Wealthcreatures.com
ONE STOCK I SEE AT VERY HIGH LEVELS IN NEXT 12 TO 18 MONTHS GALAXY SURFACTANTS CMP - 2100 TODAYS LOW - 2063 Good to Add on major dips till 1900 in sip Expecting # 2250/2500/2750/3000++ TF - 12 to 18 months S/L - As per Risk
GALAXY SURFACTANTS

NEW 52WK HIGH

3094 šŸŽÆšŸŽÆ

2100 TO 3094 āœ…āœ…

DONE IN JUST 4⃣ MONTHS

TARGETING PAISA DOUBLE

REVISED TEST LEVELS # 3300/3660/3900/4050++


Keep Trailing
Wealthcreatures.com
3 Investment Stocks : #InvestmentPick Guj Ambuja Exports 164 SL : 115 EID Pary Accumulate on dips till 395 SL 302.50 Excel Industries 1042 SL: 780.5 TF : 6-8 Months T: Minim 50-80% ++
2 Stocks from these Picks are Blasting

1 is 5% Up

Another 1 is 8% Up


Expecting minimum 50-100% Moves in next few months.

Hold tight. Sit Tight.
3 STOCK FOR PATIENCE HOLDER

1⃣ NAUKRI ( Info Edge)
CMP - 4260
Support @ 4000

2⃣ INDIA MART
CMP - 6900
Support@ 6500

3⃣ GMM PFAUDLR
CMP - 4500
Support @ 4200

TRY TO ADD MORE NEAR SUPPORT LEVELS.

ALL 3 STOCKS CAN SEE 50% TO 100% UPSIDE IN NEXT 12 T0 24 MONTHS .

S/L - 3% below support levels or As per Risk
Wealthcreatures.com
PURE INVESTMENT PICK FAIR CHEM SPECIALITY (PRIVI SPECIALITY) CMP - 692 Good To Accmulate AT CMP & ON DIPS Support @ 599/590 TEST LEVELS # 750/888/999++
PRIVI SPECIALITY
( Fairchem)


7% šŸ’ššŸ’ššŸ’£šŸ’£

New 52wk High # 1123

692 TO 1123 šŸŽÆšŸŽÆ

62% UP TILL NOW IN LESS THAN 2 MONTHS

Next Test Levels # 1200/1333/1400++
Dekhte Dekhte Nifty 200++

šŸ˜šŸ˜

Individual stock picks doing so Great ke nifty ko dekha he Nahi
šŸ”„šŸ”„šŸ”„šŸ”„šŸ”„šŸ”„šŸ”„šŸ”„šŸ”„šŸ”„
1 more stock From these Blasted šŸ’„šŸ’£ 7% after it was in 1-2% red in morning.


Seems like big Rally coming in few days

3 Breakout Stocks.

2 Safe
1 A bit Risky

All Stocks Available at Cheap Valuations.

Low PE

If we get more then 25 Likes then:

1 Stock Comming from SmallCap Space Ready for Double.

#Share #Like

www.wealthcreatures.com

https://youtu.be/HFTejXRRn0c
⭐Dhamaka Of the Day From our Portfolio Picks⭐



#Investmentpicks

Quickheal 20% UC

HesterBio 20% UC

Nahar Poly 20%

TN Petro 10%

KPIT Tech 7%

Bannari Aman 7%

Birla corp 7%

Sarla Poly 7%

Excel Ind 7%

Filatex 6%

Tinplate 5%

Kilitch Drugs 5%

Polycab 5%

Visaka Ind 5%

IF YOU STILL WAITING FOR BIG CORRECTION. YOU MAY MISS BIG RALLY.

IF YOU DON'T HAVE LARGE CAPITAL THEN INVEST SMALL AND GROW.

ABOVE ALL JUST REMEMBER 1 THING DON'T OVERLEVERAGE YOUR PORTFOLIO.

http://www.wealthcreatures.com

Link to Join Telegram Channel
šŸ‘‡šŸ‘‡šŸ‘‡šŸ‘‡šŸ‘‡šŸ‘‡

http://t.me/wealthcreature
Trading is a get rich slow scheme, when you think long term, the skys the limit.
Wealthcreatures.com
Most People Ignoring This stock But this Stock will be one of the Best Performing Stock. šŸŽÆMark My Words šŸŽÆ 700+++ is on the Way Jisko Samja Vo Target Achive Karenge. Baki Dekhte raho šŸ‘šŸ‘ https://youtu.be/3lTE1ffODz4
GNFC Q4FY21 Update YOY

Revenue
Up 29% at 1733cr vs 1342cr

EBITDA # Up 190% at 470cr vs 162cr

Margins
@ 27% vs 12%

PAT# Up 29% at 310cr vs 240cr

Improvement Also In QoQ Nos Chemicals Segment Drives Performance, Fertilizers Weak
Wealthcreatures.com
GLAND PHARMA NEW 52WK HIGH BLASTING 7% šŸ’£šŸ’£ 2611 2100 TO 2600++ TILL NOW EXPECTING # 2750/3000++ LONGTERM # 4500+++
GLAND PHARMA:

Q4 NET PROFIT 2.6B RUPEES VS 1.95B (YOY); EST 2.2B | 2.04B (QOQ)

Q4 REVENUE 8.88B RUPEES VS 6.35B (YOY)

Q4 EBITDA 3.75B RUPEES VS 2.86B (YOY)

Q4 EBITDA MARGIN 40% VS 42% (YOY)